Core Insights - The article highlights the procurement dynamics of particle size analyzers in the 37th week of 2025, indicating that while universities remain the primary purchasers, there is a notable increase in demand from pharmaceutical and energy companies [2][3] - A total of 7 bids related to particle size analyzers were reported, with a cumulative bid amount of 1.7593 million yuan [3] Procurement Overview - The procurement data covers various sectors including universities, research institutes, and corporate R&D centers, showcasing a diverse range of applications for the equipment [3] - Key brands involved in the procurement include Jinan Weina, Dandong Baite, Malvern Panalytical, and German brand Sympatec, among others [3] Specific Bids and Equipment - Jinan Weina secured 2 sets of equipment: Winner2006B and Winner319C - Dandong Baite won a bid for 1 set of BT-9300S micron particle size analyzer - Sympatec was awarded a bid for 1 set of HELOS/BR laser particle size analyzer - Beijing Times New Measurement Control Equipment Co., Ltd. won a bid for 1 TP791 oil particle size analyzer - Malvern Panalytical secured a bid for 1 laser particle size analyzer - Japan's Rion won bids for both a micron-level and a nano-level liquid optical particle size analyzer [3][4]

Core Viewpoint - Raman spectroscopy technology is a key analytical tool in various fields such as physical materials research, biomedicine, environmental monitoring, and food safety, showcasing its irreplaceable value and driving innovation and breakthroughs in both theoretical exploration and industrial practice [2]. Event Overview - The "7th Raman Spectroscopy Online Conference (iCRS2025)" will be held on September 16-17, 2025, organized by the Instrument Information Network and the Semiconductor Phonon Physics Research Group of the Chinese Academy of Sciences [2][3]. - The conference aims to gather leading experts in Raman spectroscopy technology and applications to discuss current research hotspots, providing a platform for knowledge sharing and experience exchange, thereby promoting the collaborative development of Raman spectroscopy technology and its application scenarios in China [2]. Conference Agenda Highlights - The agenda includes various sessions focusing on the application of Raman spectroscopy in physical materials, chemical fields, and biomedicine, featuring presentations from renowned researchers [4][5]. - Notable topics include in-situ SERS studies, electrochemical mechanisms, and applications in disease diagnosis and pharmaceutical industries [4][5]. Key Speakers - The conference will feature prominent researchers such as Yang Wenxing from West Lake University, Xu Yikai from East China University of Science and Technology, and others from leading institutions like Peking University and Tsinghua University [6][7][8].

Core Viewpoint - JD Industrial and SCINCO have formed a strategic partnership to enhance the procurement experience of analytical instruments in China, leveraging each other's strengths in supply chain technology and product development [1][4]. Company Overview - SCINCO, established in 1990, is the largest analytical instrument manufacturer in South Korea and a significant player in the global analytical instrument industry, exporting products to over 60 countries [3]. - JD Industrial, a subsidiary of JD Group, is a leading provider of industrial supply chain technology and services in China, serving over 10,000 key enterprise clients and millions of SMEs, including about 50% of China's Fortune 500 companies [3]. Strategic Collaboration - The partnership will see SCINCO's analytical instruments fully integrated into JD Industrial's self-operated business, making JD Industrial the launch channel for SCINCO's new products in the Chinese market [1][4]. - The collaboration aims to improve supply chain efficiency and reduce costs in the laboratory supplies industry, addressing the challenges of traditional procurement models [4][5]. Market Impact - The partnership is expected to enhance the digital transformation of the analytical instrument supply chain, making it more efficient, reliable, and agile, thereby accelerating innovation in research and development [5]. - SCINCO's CEO expressed confidence in the collaboration, highlighting JD Industrial's quality assurance and technical service capabilities as a significant opportunity for SCINCO's growth in China [5].

Core Viewpoint - The JASIS 2025 exhibition, a major event in the analytical and scientific instruments industry, is set to take place in Chiba, Japan, attracting 444 global companies and featuring over 300 activities and seminars aimed at promoting technological exchange and international cooperation [2][3]. Exhibition Overview - JASIS 2025 will open on September 3, 2025, at the Makuhari Messe in Chiba, Japan, and is recognized as one of the four major exhibitions in the analytical instruments sector, alongside Pittcon in the USA, analytica in Germany, and BCEIA in China [3]. - The event is expected to draw over 24,000 attendees, showcasing its international significance in the analytical instruments field [5]. Participation and Activities - A total of 444 companies, including several Fortune 500 scientific instrument firms, will participate, with over 1,200 exhibition booths [12]. - The event will feature 309 seminars and special activities, providing a platform for learning, exchange, and collaboration among industry professionals [12]. Focus Areas and Topics - JASIS 2025 will emphasize advanced materials, food science, environmental science, life sciences, LabDX, and quantum topics, with numerous technical seminars covering cutting-edge scientific advancements [13]. - The newly renamed "Exhibitor Seminars" will focus on new products, technologies, and methods, including drug discovery, battery material testing, PFAS, and laboratory automation [13]. International Participation - The exhibition will include 35 overseas exhibitors, with over 10 scientific instrument manufacturers from China participating, highlighting the event's role as a key gateway for the scientific instrument industry in China [14][18].

Core Viewpoint - Steel Research Nack has transitioned from reliance on imports to achieving autonomous control in ICP-OES technology over the past 40 years, significantly advancing China's high-end scientific instrument development [1][2][22]. Group 1: Historical Development - Steel Research Nack introduced the first ICP-OES in China 40 years ago, marking a new era in spectral analysis technology for the metallurgy industry [2][3]. - The company has developed a comprehensive product matrix for ICP-OES, including various models tailored for different applications, showcasing its commitment to independent research and development [2][4]. Group 2: Strategic Positioning - The company operates under a "triple identity" as a central enterprise under the State-owned Assets Supervision and Administration Commission, a publicly listed company, and a key player in the steel industry, which drives its technological breakthroughs [4][19]. - Steel Research Nack has shifted from being an "instrument user" to a "developer," addressing the challenges of high import costs and long delivery times by focusing on domestic innovation [4][7]. Group 3: Product Development - The company has achieved 100% domestic replacement of key components in ICP-OES, such as detectors and RF generators, ensuring instrument autonomy in critical fields [7][12]. - The development process emphasizes solving real user pain points, focusing on higher resolution, sensitivity, and stability, which has led to increased market acceptance and recommendations from users [12][14]. Group 4: Growth Logic - Despite economic pressures, Steel Research Nack has continued to achieve revenue and profit growth by innovating across various application fields, including rare earth and refractory metals [18][19]. - The company is expanding its service offerings to include automated laboratory solutions and customized online monitoring services, aligning with industrial smart and refined development needs [18][19]. Group 5: Industry Standards and Ecosystem - Steel Research Nack has played a significant role in standardization, leading to the development of nine standards since 2006, including an ISO standard, enhancing its influence in the industry [20][21]. - The company has established a comprehensive ecosystem around ICP-OES, including standard materials, capability verification, and metrology services, strengthening its competitive edge in the scientific instrument sector [20][21]. Group 6: Future Outlook - The company is committed to continuous innovation, transitioning its R&D model from reverse to forward development, focusing on core technical indicators to build a robust product system [19][24]. - The future of ICP-OES is seen as complementary to other technologies like ICP-MS and AAS, with a focus on maintaining its market position in routine elemental analysis [24].

Group 1 - The company reported a revenue of 1.295 billion yuan for H1 2025, a year-on-year decrease of 8.23%, and a net profit attributable to shareholders of -51 million yuan, a decline of 210.86% [1] - Revenue breakdown shows that instrument, related software, and consumables generated 896 million yuan, down 7.39%; operational services, testing services, and consulting services brought in 213 million yuan, down 11.83%; environmental equipment and engineering earned 135 million yuan, down 2.30%; and other businesses contributed 50 million yuan, down 20.51% [1] - The company maintained stable operating expenses, with sales expenses at 285 million yuan (sales expense ratio of 22.01%, up 2.38 percentage points), management expenses at 134 million yuan (management expense ratio of 10.35%, up 0.71 percentage points), R&D expenses at 203 million yuan (R&D expense ratio of 15.68%, up 0.23 percentage points), and financial expenses at 61 million yuan, a decrease of 20 million yuan due to reduced interest expenses from loan repayments [1] Group 2 - The company is a leading domestic high-end analytical instrument enterprise, continuously building a "4+X" multi-business layout, creating unique competitive barriers through the "technology platform × application field" multiplier effect [2] - Despite rapid growth in the domestic analytical instrument industry over the past decade, there remains a significant gap compared to leading countries like the US, Germany, and Japan, with the top 20 global listed analytical instrument companies being monopolized by Europe, the US, and Japan [2] - The company has been recognized as a "national manufacturing single champion enterprise" and possesses leading domestic mass spectrometry, chromatography, and spectroscopy technologies and product platforms, positioning itself to benefit from the urgent demand for domestic alternatives [2] Group 3 - Revenue forecasts for the company from 2025 to 2027 are 3.987 billion yuan, 4.506 billion yuan, and 4.951 billion yuan, with net profits of 252 million yuan, 399 million yuan, and 460 million yuan, corresponding to PE ratios of 38.10, 24.07, and 20.86 times, maintaining a "buy" rating for the company [3]

Financial Data and Key Metrics Changes - Agilent reported Q3 2025 revenue of $1.74 billion, exceeding guidance, with earnings per share of $1.37, marking a 4% year-over-year increase [9][33]. - The company raised its full-year revenue guidance to a range of $6.91 billion to $6.93 billion, reflecting a core growth of 4.5% at the midpoint, an increase of $150 million from prior guidance [10][41]. - Gross margins for Q3 were 53.1%, down year-over-year due to tariffs, currency impacts, and downtime related to capacity expansion [34]. Business Line Data and Key Metrics Changes - The pharmaceutical segment grew 9% in Q3, with small molecule growth in double digits driven by downstream QAQC demand and adoption of the Infinity Tree LC platform [20][21]. - Chemical and Advanced Materials saw a 10% growth, supported by capital investments in semiconductor and chemical sectors [21][22]. - The Life Sciences and Diagnostics market grew 7% core, with strong performance in LC and LC MS instruments [22][23]. Market Data and Key Metrics Changes - Demand outside The Americas grew in the low 30s, with significant contributions from Asia ex China and EMEA [14][24]. - In Asia ex China, growth was 10%, driven by supply chain reshoring and increased safety regulations [27]. - The U.S. market faced challenges, particularly in biopharma spending, but overall growth in small molecule pharma and chemicals was noted [29][30]. Company Strategy and Development Direction - Agilent's Ignite enterprise operating model is a key growth driver, enabling faster decision-making and cost savings [14][16]. - The company is focused on innovation, with new product launches like the Infinity Tree LC platform and Pro IQ LC MS system driving growth [17][18]. - Agilent aims to fully mitigate tariff impacts by 2026 through strategic supply chain management and pricing adjustments [30][80]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustained revenue growth, with Q4 expected to be the largest revenue quarter of the year [18][19]. - The company anticipates a sequential operating margin improvement in Q4, driven by increased revenue and Ignite benefits [20][36]. - Management noted that customer budgets in pharma are normalizing, leading to larger quotes and expected spending increases by year-end [54][74]. Other Important Information - The company experienced higher tariff expenses than previously expected, impacting margins but is on track to mitigate these costs moving forward [35][42]. - Operating cash flow was $362 million in Q3, down from last year due to increased working capital and tariff-related inventory build [37]. Q&A Session Summary Question: Can you unpack the margin variables? - Management highlighted that higher tariffs, increased variable pay, and incremental commercial investments were the main factors affecting margins [46][47]. Question: What is the outlook for NASD? - NASD is expected to continue strong momentum, with high single-digit to double-digit growth anticipated [51][56]. Question: How widespread is the reduced dependency on sign-offs? - This trend is noted across all geographies, particularly in small molecule and large pharma, improving momentum for Agilent [60][61]. Question: What are the expectations for 2026? - While it's early to provide detailed guidance, management sees a solid foundation for growth in 2026, with tariffs expected to be fully mitigated [70][72]. Question: How is the trade tariff dynamics influencing customer behavior? - Management reported no significant pull forwards or stocking behaviors, with strong lab activity supporting demand [94][96].

Core Viewpoint - The article highlights the total bid amount of 2.404 million yuan for particle size analyzers in the 33rd and 34th weeks of 2025, covering various sectors such as petrochemicals, higher education, and medical fields [1][2]. Summary by Sections Bid Information - A total of 10 bids related to particle size analyzers were published from August 11 to August 24, 2025, with a total bid amount of 2.404 million yuan [2]. - The procurement needs span across industries including petrochemicals, higher education, medical devices, and pharmaceutical testing, with brands such as Dandong Better, Zhuhai OMEK, Shandong NKT, and American PSS involved [2]. Bid Details - The following table summarizes the bid announcements: - **August 18, 2025**: Laser particle size analyzer by Huihong Derui for Sinopec [3]. - **August 18, 2025**: Laser particle size analyzer by Changchun Tongxing for Jidong Cement [3]. - **August 18, 2025**: Fully automatic laser particle size analyzer NKT5200-H by Shandong NKT, bid amount 58,500 yuan for Wuxi Vocational Technical College [3]. - **August 19, 2025**: Spray laser particle size analyzer Better s i ze2000S by Dandong Better, bid amount 84,000 yuan for Fujian Provincial Vocational and Technical College [3]. - **August 20, 2025**: Laser particle size analyzer LS900 by OMEK, bid amount not specified for CPIC [3]. - **August 20, 2025**: Dynamic light scattering particle size analyzer Nicomp Z3000 by American PSS, bid amount 498,000 yuan for Wuxi Drug Safety Inspection Center [3]. - **August 20, 2025**: Spray laser particle size analyzer, bid amount 78,000 yuan for Zhejiang Medical Device Inspection Research Institute [4]. - **August 22, 2025**: Laser particle size analyzer BT-9300S by Dandong Better, bid amount 796,500 yuan for Shanxi University of Science and Technology [4]. Product Features - The Better s i ze2000S is designed for testing droplet size distribution, featuring a wide dynamic range, good accuracy, and ease of operation, suitable for various applications including pesticide and pharmaceutical spray evaluations [5]. - The BT-9300S is a practical laser particle size analyzer with a modular structure, suitable for small to medium-sized laboratories in production and research [6]. - The LS900 model is noted for its advanced measurement capabilities, particularly for sub-micron powders [7]. - The Tops i zer Plus offers a wide measurement range and is favored in industries such as chemicals and pharmaceuticals [8][9]. - The Nicomp 3000 Z3000 series utilizes advanced dynamic light scattering principles for particle size distribution analysis, enhancing resolution and sensitivity [10]. - The NKT5200-H employs advanced Mie scattering principles, ensuring measurement accuracy and repeatability [11].

Core Insights - As of August 17, 25 companies listed on the Beijing Stock Exchange disclosed their 2025 semi-annual reports, with 22 companies reporting year-on-year revenue growth [1] - Notably, Zhuozhao Adhesive achieved the highest revenue growth rate at 207.46%, while several other companies, including Binhang Technology, Jinbo Biology, Tongxin Transmission, Haineng Technology, and Mingyang Technology, reported revenue growth rates exceeding 30% [1] - Zhuozhao Adhesive and Jinbo Biology plan to distribute interim dividends, indicating a commitment to returning value to investors [1] Revenue and Profit Performance - Among the 25 companies that disclosed their mid-year reports, 24 reported positive net profits, with only Optai experiencing a loss [2] - 18 companies saw year-on-year growth in net profit, with Zhuozhao Adhesive, Haineng Technology, and Yingtai Biology successfully turning losses into profits [2] - Zhuozhao Adhesive reported a revenue of 156 million yuan, a 207.46% increase year-on-year, and a net profit of 26.78 million yuan, recovering from a loss of 12.03 million yuan in the same period last year [2] - The growth in Zhuozhao Adhesive's performance is attributed to increased demand in end-use applications, accelerated acceptance of existing projects, progress in new market development, and improved cost control and operational efficiency [2] Sector-Specific Insights - Yingtai Biology also turned a profit in the first half of 2025, reporting a revenue of 2.966 billion yuan, a 3.04% increase, and a net profit of 15.29 million yuan, recovering from a loss of 79.38 million yuan [3] - The agricultural chemical sector is experiencing a structural recovery, with improved supply and demand dynamics and price increases in certain product segments due to seasonal demand and overseas restocking [3] - Haineng Technology reported a total revenue of 136 million yuan, a 34.87% increase, and a net profit of 5.47 million yuan, recovering from a loss of 14.02 million yuan [3] - The company is focusing on high-efficiency chromatography instruments and expanding into new market segments, which contributed to a 61.71% increase in revenue from chromatography and spectroscopy products [3] Dividend Distribution Plans - As of August 17, Zhuozhao Adhesive, Jinbo Biology, and two other companies plan to distribute a total cash dividend of 176 million yuan [4] - Zhuozhao Adhesive plans to distribute 2.20 yuan per 10 shares, totaling approximately 18.06 million yuan [4] - Jinbo Biology intends to distribute 10 yuan per 10 shares, amounting to about 115 million yuan, with a revenue of 859 million yuan and a net profit of 392 million yuan, reflecting a year-on-year growth of 42.43% and 26.65%, respectively [4] - Mingyang Technology plans to distribute 2.25 yuan per 10 shares, with a total cash dividend of around 30 million yuan, reporting a revenue of 167 million yuan and a net profit of 31.88 million yuan, a slight decrease of 4% year-on-year [4] - Jianbang Technology also announced a cash dividend of 2 yuan per 10 shares, totaling approximately 13.16 million yuan, with a revenue of 375 million yuan and a net profit of 49.41 million yuan, reflecting a year-on-year growth of 20.77% and 27.18%, respectively [5]

Core Viewpoint - The article highlights various high-paying job opportunities in the analytical instrument sector, emphasizing the demand for skilled professionals in sales and technical roles across different companies [2][3][4][5][7][9][10][12][16][18]. Group 1: Job Opportunities - Shimadzu is hiring for a Sales Representative position in Chengdu with a salary range of 8k-13k per month [2]. - Agilent is looking for an Application Engineer specializing in Gas Chromatography in Shanghai, offering a salary between 25k-35k per month [4]. - Pannuo is seeking a Mass Spectrometry Technical Leader in Shanghai, with a salary range of 50k-90k per month [5]. - Zhonghang Shijinshi is recruiting a Nuclear Power Materials Sales Representative in Langfang, with a salary of 15k-20k per month [7]. - Meipuda is hiring a Client Manager in Shanghai, offering a salary range of 10k-15k per month [9]. Group 2: Job Requirements - For the Sales Representative position at Shimadzu, candidates should have a bachelor's degree in relevant fields and at least 2 years of sales experience, with a strong emphasis on communication skills and customer satisfaction [3]. - The Application Engineer role at Agilent requires a bachelor's or master's degree in analytical chemistry or related fields, along with over 7 years of relevant work experience [4]. - The Mass Spectrometry Technical Leader position at Pannuo demands a master's or doctoral degree with over 5 years of R&D experience in mass spectrometry [6]. - The Nuclear Power Materials Sales Representative role requires a bachelor's degree and at least 3 years of sales experience in the nuclear power or electricity industry [8]. - The Client Manager position at Meipuda requires a bachelor's degree and at least 2 years of relevant work experience, with strong communication skills [10].